Dr. Markus Roggen, President and Chief Science Officer for Delic Labs, will participate in a panel discussion about building scientific trust and using research and development to differentiate a brand and maximize revenues…

KWC will serve more patients than any other ketamine therapy provider with addition of Medicare, cements status as nation’s largest ketamine clinic network in the U.S. Medicare coverage will be available for patients in eight cities with more to come

Nation’s Largest Ketamine Therapy Provider to Offer FDA-Approved Esketamine Nasal Spray to Veterans at Nine KWC Clinics

Matt Stang, executive chairman of Delic, will discuss the company’s efforts to grow the clinic footprint, accept a wider selection of insurance options, and its strategic outlook for the remainder of the year

Matt Stang, Co-founder and CEO of Delic, and Kevin Nicholson, COO of Delic, have been elevated to Executive Chairman and Chief Executive Officer, respectively.

Delic Holdings Corp a leader in new medicines and treatments for a modern world, is pleased to announce that it completed the sale of 1,240 units at a price of $1,000 per Unit for aggregate gross proceeds of $1,240,000, on July 27, 2022

Ketamine Wellness Centers (KWC) Approaches 100,000 Treatments, Expands FDA-Approved SPRAVATO® to Minneapolis, Salt Lake City, Dallas with More Locations Soon

The Cannabis Scientist Power List is an annual recognition of the most important innovators within the cannabis industry. Dr. Roggen has been named to the list for the third consecutive year.